HCPCS Level IIdrugActive
J0349
Inj, rezafungin, 1 mg
BETOS: O1E
Effective: 2023-10-01
Description
Injection, rezafungin, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rezzayo
Manufacturer
Melinta Therapeutics, LLC
HCPCS Dosage
1 MG
Billing Units
200.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.